The Olivieri Report: The Complete Text Of The Report Of The Independent Inquiry Commissioned By The Canadian Association by Jon ThompsonThe Olivieri Report: The Complete Text Of The Report Of The Independent Inquiry Commissioned By The Canadian Association by Jon Thompson

The Olivieri Report: The Complete Text Of The Report Of The Independent Inquiry Commissioned By The…

byJon Thompson, Patricia Baird, Jocelyn Downie

Paperback | October 30, 2001

Pricing and Purchase Info

$29.95

Earn 150 plum® points

Prices and offers may vary in store

Quantity:

Ships within 3-5 weeks

Ships free on orders over $25

Not available in stores

about

In 1996, Dr. Nancy Olivieri identified an unexpected risk associated with a drug she was testing to treat a rare blood disorder. When she moved to inform patients of this risk as required by medical ethics, the drug manufacturer, Apotex, terminated the research trial and threatened to take legal action.

This was the opening salvo in a long contest involving Olivieri, Apotex, Toronto's Hospital for Sick Children, and the University of Toronto. Olivieri expected to receive support on the ethical issue from the hospital and the university, but neither institution provided effective support against ongoing legal harassment by Apotex. Intense media coverage followed the case from beginning to end.

The Olivieri Report is the report of an independent inquiry--commissioned by the Canadian Association of University Teachers--into the case, conducted by three widely respected Canadian academics.
JON THOMPSON is a Professor and Chair of the Department of Mathematics and Statistics at the University of New Brunswick. PATRICIA BAIRD holds the position of University Distinguished Professor at the University of British Columbia and is a member of UBC's Department of Medical Genetics. JOCELYN DOWNIE is an Associate Professor in the ...
Loading
Title:The Olivieri Report: The Complete Text Of The Report Of The Independent Inquiry Commissioned By The…Format:PaperbackDimensions:584 pages, 9 × 6 × 1 inPublished:October 30, 2001Publisher:James Lorimer & Company Ltd., PublishersLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1550287397

ISBN - 13:9781550287394

Look for similar items by category:

Reviews

Table of Contents

Key to Abbreviations
A. Overview
B. Lessons To Be Learned
C. Findings
D. Recommendations


Report
1. The Committee of Inquiry
2. Background Information
3. Policy Context
4. The Context of Associations between Apotex Inc. & the University of Toronto
5. Review & Analysis of Events

The Toronto L1 trials (LA-01 and LA-03
Designing and organizing the international trial (LA-02)
Progress of the Toronto trials (LA-01 and LA-03
Concerns arising in 1995
Identification of the first risk
Trial terminations and legal warnings
Post-termination events
Expanded disclosure
Ongoing legal warnings
Trial close-outs and another stoppage in supply of L1
Identification of the second risk
Events at the Hospital from June 1997 to August 1998
Removal of Dr. Olivierl as Program Director
Events at the University of Toronto
The Naimark Review Process and Report
The Medical Advisory Committee Proceedings
The MAC allegations in regard to liver biopsies
The central role of Dr. Koren in the L1 controversy
Involvement of the CAUT and the UTFA
Public interest, public policy, contracts, and legal representation
The Involvement of Government Regulatory Agencies

NOTES
APPENDICES*

*Appendix I contains a detailed table of contents for the entire report.

Editorial Reviews

"The Report of the Committee of Inquiry...is hard for me to read. It opens old wounds for me and my closest supporters as we study its 540 pages. "...I am pleased that the report fully vindicates me. But after five years, my colleages and I have lost faith in the administrations of the hospital and the University of Toronto, whose duty it is to protect researchers' academic freedom and the public's right to know. More important than setting the record straight are the general lessons to be learned from this saga."...Not one of us believes that the report represents the end of this struggle -- that's still being fought, on several fronts. But if we act on the committee's recommendations, it might be the end of the beginning."